Anil K. Sood

The University of Texas Graduate School of Biomedical Sciences at Houston 
Cell Biology, Molecular Biology, Oncology
"Anil Sood"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Glassman D, Bateman NW, Lee S, et al. (2022) Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer. Cancers. 14
Wu Y, Jennings NB, Sun Y, et al. (2022) Targeting CCR2 macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer. Journal of Cancer Research and Clinical Oncology
Thaker PH, Han LY, Kamat AA, et al. (2021) Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nature Medicine
Sasano T, Gonzalez-Delgado R, Muñoz NM, et al. (2021) Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer. Journal of Thrombosis and Haemostasis : Jth
Niu N, Yao J, Bast RC, et al. (2021) IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming. Oncogenesis. 10: 65
Handley KF, Rodriguez-Aguayo C, Ma S, et al. (2021) Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models. Molecular Cancer Therapeutics
Corvigno S, Burks JK, Hu W, et al. (2021) Immune microenvironment composition in high-grade serous ovarian cancers based on BRCA mutational status. Journal of Cancer Research and Clinical Oncology
Liu Y, Zhang X, Han C, et al. (2021) Author Correction: TP53 loss creates therapeutic vulnerability in colorectal cancer. Nature
Lutgendorf SK, Ramirez E, Schrepf A, et al. (2021) Rural residence is related to shorter survival in epithelial ovarian cancer patients. Gynecologic Oncology
Wu Y, Huang J, Ivan C, et al. (2021) MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer. Gynecologic Oncology
See more...